feed,title,long_url,short_url
Investing,Earnings call: Nextracker reports a 50% year-over-year revenue growth,https://www.investing.com/news/stock-market-news/earnings-call-nextracker-reports-a-50-yearoveryear-revenue-growth-93CH-3553145,https://da.gd/FE7Q1
Investing,Earnings call: Vanda Pharmaceuticals reported a net loss of $8.7 million for 1H,https://www.investing.com/news/stock-market-news/earnings-call-vanda-pharmaceuticals--reported-a-net-loss-of-87-million-for-1h-93CH-3553144,https://da.gd/66xqOQ
Investing,Earnings call: Arteris reports strong Q2 driven by AI and Automotive demand,https://www.investing.com/news/stock-market-news/earnings-call-arteris-reports-strong-q2-driven-by-ai-and-automotive-demand-93CH-3553138,https://da.gd/EyRha
Investing,Earnings call: Office Properties successfully completed $1.3 billion in secured financing,https://www.investing.com/news/stock-market-news/earnings-call-office-properties-successfully-completed-13-billion-in-secured-financing-93CH-3553136,https://da.gd/waVivv
Investing,Earnings call: Tandem Diabetes Care reports a 2Q growth of $222 million in 2024,https://www.investing.com/news/stock-market-news/earnings-call-tandem-diabetes-care-reports-a-2q-growth-of-222-million-in-2024-93CH-3553127,https://da.gd/I4TWN
Investing,Earnings call: Cerus Corporation raises annual revenue guidance,https://www.investing.com/news/stock-market-news/earnings-call-cerus-corporation-raises-annual-revenue-guidance-93CH-3553116,https://da.gd/Xy9Lp
Investing,Earnings call: PDS Biotech outlines plans for Versamune HPV trials,https://www.investing.com/news/stock-market-news/earnings-call-pds-biotech-outlines-plans-for-versamune-hpv-trials-93CH-3553110,https://da.gd/5t38o
Investing,Earnings call: INmune Bio Reports Progress in Oncology and Alzheimer's Trials,https://www.investing.com/news/stock-market-news/earnings-call-inmune-bio-reports-progress-in-oncology-and-alzheimers-trials-93CH-3553101,https://da.gd/h2yll
Investing,Earnings call: Zymeworks reports progress and strategic shifts in Q2 2024,https://www.investing.com/news/stock-market-news/earnings-call-zymeworks-reports-progress-and-strategic-shifts-in-q2-2024-93CH-3553102,https://da.gd/WqBdAp
Investing,Earnings call: Syndax Pharmaceuticals outlines robust Q2 2024 outlook,https://www.investing.com/news/stock-market-news/earnings-call-syndax-pharmaceuticals-outlines-robust-q2-2024-outlook-93CH-3553098,https://da.gd/bsL5Y
